Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E Apostolou
Observed names:
Apostolou, Efstratios,
E A Apostolou,
E APOSTOLOU,
E.A. Apostolou,
Efstratios A Apostolou,
Efstratios A. Apostolou
show all 6
Institutions:
National and Kapodistrian University of Athens,
London School of Economics and Political Science
Observed institutions:
National and Kapodistrian University of Athens,
University General Hospital Attikon,
London School of Economics and Political Science
ORCID:
0000-0001-9940-7473
Observed ORCID:
0000-0001-9940-7473
OpenAlex ID:
A5055230308
The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspective
2023
·
Efstratios A. Apostolou
, Anna-Maria Fontrier
, et al.
·
Hellenic Journal of Cardiology
·
16
PDF
Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries
2022
·
E A Apostolou
, C A Main
, et al.
·
European Heart Journal
·
6
Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease
2026
·
Jennifer L Gill
, Aurelio Miracolo
, et al.
·
European Journal of Preventive Cardiology
·
4
Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper
2026
·
Anzhela Soloveva
, Jin Joo Park
, et al.
·
European Journal of Heart Failure
MSR1 Estimating Lifetime Benefits of Optimizing Secondary Preventive Treatment for Atherosclerotic Cardiovascular Disease
2023
·
J.L. Gill
, A. Miracolo
, et al.
·
Value in Health
PDF
In-hospital prognosis of patients with primary and secondary acute heart failure diagnosis
2020
·
E Apostolou
, P Rafouli-Stergiou
, et al.
·
European Heart Journal
P923Association of intra-abdominal pressure changes with early diuretic response and improvement of dyspnea in patients with acute heart failure
2018
·
E Apostolou
, N Holevas
, et al.
·
European Heart Journal
405 Serum profiles of matrix metalloproteinases and their inhibitor in patients with acute decompensation of chronic heart failure and left ventricular hypertrophy or dilatation
2003
·
D TZIAKAS
, G CHALIKIAS
, et al.
·
European Journal of Heart Failure Supplements
485 Differences in serum activity of matrix metalloproteinases between diabetic and non-diabetic patients with chronic heart failure
2003
·
D TZIAKAS
, G CHALIKIAS
, et al.
·
European Journal of Heart Failure Supplements
Show more works
View as search
Works count:
10
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type